Argenica (AGN) is an exact example you can use because NYR targets the same mechanism of action as AGN
Phase 1 cost for AGN was around 3.5 million dollars company has more than enough money to de risk the safety of the drug and AGN has already proven up the efficacy and mechanism of action for the drug NYR. Do some research before posting
AGN completed phase 1 - 100 million market cap
NYR fully funded for phase 1 plus access to non dilutive funding from the US defence force - 6 million market cap
Hawk70 anyone listening to your uneducated posting and selling just gave a lot of people easy entries. Keep posting
Argenica (AGN) is an exact example you can use because NYR...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $164.0K | 1.456M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 742920 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 254495 | 3 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| NYR (ASX) Chart |